Attovia Therapeutics Appoints Hubert Chen As Chief Medical Officer
03/26/24, 11:20 AM
Location
san carlosIndustry
therapeutics
biotechnology
Position
chief medical officer
Attovia Therapeutics has announced the appointment of Hubert Chen, M.D., MPH, as Chief Medical Officer, effective March 21, 2024. Dr. Chen will lead the company’s clinical development and regulatory functions and will serve on the Executive Committee
Company Info
Location
san carlos, california, united states
Additional Info
Attovia is creating a pipeline of biotherapeutics for the treatment of immune-mediated diseases. We leverage ATTOBODY™, our proprietary biologics platform, to generate first-in-class and best-in-class bispecifics and multispecifics.